Kaleidoscope.bio

Task assigned, task done ✅ With Kaleidoscope, notify teammates, communicate timelines, upload data, and track every action—all in one place. https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics

Ready to accelerate scientific breakthroughs? On the latest episode of the AWS Health Innovation Podcast, Yin He chats with Bogdan Knezevic, Co-Founder & CEO of Kaleidoscope.bio, about reshaping R&D in biotech and pharma. Discover how their platform: ✅ Organizes projects & tracks key decisions ✅ Streamlines experimental data management ✅ Measures R&D impact & productivity 🎧 Listen now: https://go.aws/3AWYJ8v #AWS #HealthInnovation #Biotech

Your data, always within reach. Kaleidoscope’s entity browser makes finding what you need effortless with just one click. 🔍 https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics

Check out this conversation between Yin He of Amazon Web Services (AWS)'s Healthcare + Life Sciences team, and our CEO Bogdan Knezevic, on operational challenges facing R&D teams (and how Kaleidoscope can help).

Imagine going through all the work of finalizing a major pharma partnership - years of R&D, millions of dollars, complex negotiations - only to have the deal fall through because of poorly-defined KPIs. Surprisingly (or not, for those involved in these deals), this is more common than you might think. Deals signed between biotechs and pharma can easily unravel, if both sides are not on the exact same page about what milestones need to be met, against what timelines, and with what supporting data. I posted about this last week; here are some more thoughts on the topic: https://lnkd.in/gDQmVJ2e If anything sparks your interest, feel free to DM me!

Partnership deals are a big part of the business of biotech. Instilling confidence that your team will deliver on key milestones in time is paramount to success. This week alone, we saw several partnership announcements, of various flavors. Roche teaming up with Flare Therapeutics, GSK working with Vesalius Therapeutics, Novartis paying Schrödinger, Autolus Therapeutics receiving a milestone payment from Blackstone Life Sciences. It sounds simple, but aligning both sides on what the overall (and phased) timeline is + what technical KPIs need to be hit is critically important. Both in negotiating the deals to begin with, and in ensuring a favorable outcome on the other side of the work. Not getting this right can lead to major issues: from painful bleeding of R&D dollars and team time, to deals that fall through entirely (or, worse, lead to litigation). Keeping accurate records of project milestones, communally-defined technical KPIs, and the key data that underpins major decisions, is worth the investment. There are a few ways to achieve this. At Kaleidoscope, we’ve made it easy for teams to set up KPI, data, and decision trackers that capture this information automatically, without the need for significant lift from the program or BD teams. In fact, it reduces the overall amount of work that biotechs need to do, and provides clarity on progress for both sides of the partnership. Check us out and reach out if relevant to you and your partnership team! https://lnkd.in/eRrWcPwt

A few Kaleidoscopians took to the streets last week and ran the 2024 NYC marathon (as first-time marathoners!). Incredible sunshine and energy throughout all five boroughs -- congrats to all who ran!

"Are you an AI company?" might be one of the most expensive questions in biotech right now. Forcing this narrative can lead to biotech companies picking sides and making costly mistakes that lead them to over or under-invest in the ways they advance their R&D and programs. Rather than picking a side ('traditional biotech' versus 'AI company'), the sharpest leaders and most competitive companies will find ways to weave in elements from both angles. And, over time, the conversations will hopefully evolve away from "which one are you?" and more towards whether companies are covering their blind spots and leveraging every edge they can be, in their race to getting drugs to market. https://lnkd.in/dkCtnDtK

Ready to boost your team’s productivity? 🚀 Kaleidoscope’s Slack integration minimizes downtime with live notifications & seamless handoffs. https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics

Spooked by messy planning? 👻 Task templates bring order to your design cycles—keeping projects on track and scare-free! 🎃 #StreamlineSuccess https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics